Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
Major Ileana Hauge, Chief of Applied Toxicology Research atWright-Patterson Air Force Base, stated, "The U.S. Air Force has realized forsome time that a commercial off-the-shelf solution to manage the ArmedServices Blood Program is impractical. CAMRIS and Wyndgate have demonstratedthat a custom solution built to our specific needs from the backbone of the ElDorado Donor(TM), Donor Doc(TM) and SafeTrace(R) platforms is the winningalternative. These vendors have demonstrated their merit and we haveconfidence in the outcome as we progress through Phase-II."
Advertisement
CAMRIS has partnered with Global Med's Wyndgate Technologies(R) divisionsince 2006. Last year, under a Department of Defense Small BusinessInnovation Research (SBIR) Program, the partnership won a Phase-I competitivebid, demonstrating the scientific and technical merit and feasibility ofdeveloping a global software system to provide universal access to donoridentity, deferrals and travel history. The goal is to create continuityacross blood bank facilities, thereby helping to increase the safety of theArmed Forces' global blood supply. Phase-I included demonstration of aprototype solution modeled after the platform of Wyndgate's El Dorado Donor,Donor Doc, and SafeTrace solutions.
After winning the Phase-I award, the companies submitted and recently wona joint proposal to continue the project in Phase-II, to customize thesoftware for clinical settings to support robust, accurate and consistentperformance and provide a secure interface to be used worldwide. The Phase-IIaward is significant in that it advances the project from prototype throughdevelopment, culminating in potential commercialization and roll-out.
Merits of the Phase-II advancement include confidence from the Air Forceand Armed Services Blood Program that the project has technical and scientificmerit, that commercial application is promising, and that there is evidence ofthe competency and qualifications of the principal investigator team todeliver results. Ultimately, the software solution may be employed to fulfillthe needs not only of the U.S. Air Force, U.S. Navy and U.S. Army, but also ofNATO alliance countries as the need to track and move blood increases withglobalization of services.
After an extensive evaluation by the Wright Patterson Air Force ResearchLaboratory, an independent report determined that CAMRIS and Wyndgateexhibited dedicated technical and professional resources committed to the SBIRproject, and that their software products were proven in the industry andtrusted by blood bankers. The partners also possess a broad continuum ofknowledge about SBIR. In addition, the evaluation concluded that CAMRIS andWyndgate have proven project management and blood computer database systemimplementation and support experience and have the documented ability todeliver solutions that solve complex and diverse business needs that will beneeded globally in the Armed Forces and with NATO.
Carlos Rivera, CEO of CAMRIS International, stated, "We believe theCAMRIS/Wyndgate team has a unique combination of experience in health care,technological innovation, and support for the Armed Forces. Mr. Riveracontinued, "We are confident that this will be the perfect opportunity tocombine our capabilities and continue into a future Phase-III in which thesolution has the potential to be commercialized among all government agenciesdomestically and internationally."
Mick Ruxin, M.D., Chairman and CEO of Global Med Technologies, Inc.,stated, "We are proud to advance to Phase-II with this SBIR." Dr. Ruxincontinued, "The confidence placed in us by the Department of Defense is atestament to our commitment to help the U.S. Armed Forces and NATO to providesafety and security for the global military blood supply. We are excited toadd yet another dimension to our global footprint as we move forward withCAMRIS and the dedicated individuals at Wright Patterson Air Force Base."
About CAMRIS International
CAMRIS delivers comprehensive and customized services in the areas ofknowledge management, public health, international development, medicalservices and technology solutions. CAMRIS is a unique, fast growing, dynamicsmall business and has project experience spanning more than 1,300 completedtasks and activities for more than 300 clients over the past 50 years. CAMRISInternational is a certified 8(a), Service Disabled Veteran Owned, and acertified Maryland MBE, facility-cleared, small disadvantaged business.
For more information about CAMRIS International, please call(301) 770-6000 or visit http://www.camrisinternational.com orhttp://www.camris.net
About Global Med Technologies, Inc.
Global Med Technologies(R), Inc. is an international medical softwarecompany which develops regulated and non-regulated software products andservices for the healthcare industry. As a leading provider of blood andlaboratory software applications and services, Global Med's products aredeployed in 20 countries and serve over 1,600 transfusion centers, blood banksand laboratories.
Global Med's U.S. division, Wyndgate Technologies(R), providesVein-to-Vein(R) tracking through its Donor Doc(TM), SafeTrace(R), SafeTraceTx(R) and El Dorado Donor(TM) software products. Each year, Wyndgate'sproducts and services manage more than eight million blood components,representing over 27% of the U.S. blood supply.
Global Med's European subsidiary, Inlog, SA, is a leading provider ofdonor center and transfusion management systems as well as cellular therapysoftware, laboratory information systems and quality assurance medicalsoftware systems internationally. Inlog's products include EdgeBlood*,EdgeTrack*, EdgeCell, EdgeLab and SAPA.
Global Med's U.S. division, eDonor(R), provides a web-based donorrelationship management system that integrates recruitment, scheduling,retention and fulfillment for national as well as local community bloodcenters and hospitals. eDonor's products and services are designed tocomplement Global Med's strong line of international blood management andlaboratory information software and service solutions.
Global Med's U.S. subsidiary, PeopleMed(R), Inc., provides cost-effectivecustomized software validation, consulting and compliance solutions tohospitals and donor centers.
For more information about Global Med's products and services, please call800-996-3428 or visit http://www.globalmedtech.com, http://www.peoplemed.com,http://www.inlog.com, http://www.eDonor.com, and http://www.wyndgate.com.
*FDA 510(k) clearance required prior to sales in the U.S.
This news release may include statements that constitute forward-lookingstatements, usually containing the words "believe," "estimate," "project,""expects" or similar expressions. These statements are made pursuant to thesafe harbor provisions of the Private Securities Litigation Reform Act of1995. Forward-looking statements inherently involve risks and uncertaintiesthat could cause actual results to differ materially from the forward-lookingstatements. By making these forward-looking statements, the Companyundertakes no obligation to update these statements for revisions or changesafter the date of this news release.
SOURCE Global Med Technologies, Inc.
